Lactose and Bovine Milk Oligosaccharides Synergistically Stimulate B. longum subsp. longum Growth in a Simplified Model of the Infant Gut Microbiome

J Proteome Res. 2019 Aug 2;18(8):3086-3098. doi: 10.1021/acs.jproteome.9b00211. Epub 2019 Jul 10.

Abstract

Increasing awareness of the importance of a healthy Bifidobacterium-rich microbiome has led to a need for more knowledge on how different prebiotic carbohydrates specifically impact the infant microbiome, especially as a community instead of single bacterial targets. In this study, we combined proton nuclear magnetic resonance (1H NMR) metabolomics and molecular biology methods for quantification of bacteria to compare the prebiotic effect of bovine milk oligosaccharides (BMO) and synthetic galacto oligosaccharides (GOS) using mono- and cocultures of eight major bacteria related to a healthy infant microbiome. The results revealed that BMO treatments supported growth of Bifidobacterium longum subsp. longum and Parabacteroides distasonis, while at the same time growth of Clostridium perfringens and Escherichia coli was inhibited. In addition, there was a synergistic effect of combining lactose and BMO in regards to reducing C. perfringens, maintaining stable numbers of P. distasonis and simultaneously increasing numbers of the beneficial B. longum subsp. longum. These results indicate that the oligosaccharide composition plays a vital role in shaping the developing microbiota.

Keywords: NMR metabolomics; commensal microbiome; gut bacteria; infant nutrition; microbial interactions; pathogen inhibition; prebiotic oligosaccharides; symbiotic interactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacteroidetes / drug effects
  • Bacteroidetes / growth & development
  • Bifidobacterium / drug effects*
  • Bifidobacterium / growth & development
  • Cattle
  • Clostridium perfringens / drug effects
  • Clostridium perfringens / growth & development
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development
  • Galactose / metabolism
  • Galactose / pharmacology
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / genetics
  • Humans
  • Infant
  • Lactose / metabolism*
  • Lactose / pharmacology
  • Magnetic Resonance Spectroscopy
  • Milk / chemistry
  • Milk / microbiology
  • Oligosaccharides / chemistry
  • Oligosaccharides / pharmacology
  • Prebiotics / microbiology*

Substances

  • Oligosaccharides
  • Prebiotics
  • Lactose
  • Galactose

Supplementary concepts

  • Parabacteroides distasonis